Marshall Wace, LLP Natera, Inc. Put Options Transaction History
Marshall Wace, LLP
- $78.4 Billion
- Q4 2024
Put Options
1 transactions
Others Institutions Holding NTRA
# of Institutions
634Shares Held
123MCall Options Held
821KPut Options Held
1.01M-
Vanguard Group Inc Valley Forge, PA12.3MShares$2 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY6.77MShares$1.1 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.74MShares$1.09 Billion0.12% of portfolio
-
Jpmorgan Chase & CO New York, NY6.7MShares$1.09 Billion0.09% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.43MShares$719 Million3.74% of portfolio
About Natera, Inc.
- Ticker NTRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 96,957,400
- Market Cap $15.7B
- Description
- Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...